Related Experiment Video

Updated: Aug 31, 2025

Concomitant Isolation of Primary Astrocytes and Microglia for Protozoa Parasite Infection
09:34

Concomitant Isolation of Primary Astrocytes and Microglia for Protozoa Parasite Infection

Published on: March 18, 2020

7.8K

Anti-Tumor Effect of Parasitic Protozoans

Haojie Ding1, Songrui Wu1, Zi Jin1

  • 1School of Basic Medical Sciences and Forensic Medicine, Hangzhou Medical College, Hangzhou 310059, China.

Bioengineering (Basel, Switzerland)
|August 25, 2022
PubMed

Insights

Protozoan parasites can activate the immune system to fight tumors. Further research into parasitic antigens and modified parasites may lead to novel cancer treatments.

Area of Science:

  • Immunology
  • Molecular Biology
  • Oncology

Background:

  • The immune system's aberrant silencing against "altered self" can lead to malignancies.
  • Understanding the relationship between parasites and tumors has shifted focus from elimination to utilization of parasitic pathogens.

Purpose of the Study:

  • To review the antitumor effects of parasitic infection or parasitic antigen induction.
  • To explore the immune mechanisms involved in modulating cancer progression by parasites.

Main Methods:

  • Literature review of studies on parasitic infection and antitumor effects.
  • Analysis of immune mechanisms modulating cancer progression.

Main Results:

  • Protozoan parasites and their products demonstrate confirmed antitumor impact.
  • Parasitic infections activate and enhance the immune system, inhibiting tumor growth, angiogenesis, and metastasis in animal models.

Conclusions:

  • Despite limited clinical trials and unclear specific mechanisms, parasitic approaches show promise.
  • Genetically modified protozoan parasites and derived molecules, combined with chemotherapy, represent a potential future direction for antitumor treatment.
Keywords:
anti-tumorbiotherapyimmune responseprotozoontumor microenvironment

More Related Videos

Testing Protozoacidal Activity of Ligand-lytic Peptides Against Termite Gut Protozoa in vitro Protozoa Culture and in vivo Microinjection into Termite Hindgut17:36

Testing Protozoacidal Activity of Ligand-lytic Peptides Against Termite Gut Protozoa in vitro Protozoa Culture and in vivo Microinjection into Termite Hindgut

Published on: December 29, 2010

15.0K
A Parasite Rescue and Transformation Assay for Antileishmanial Screening Against Intracellular Leishmania donovani Amastigotes in THP1 Human Acute Monocytic Leukemia Cell Line12:22

A Parasite Rescue and Transformation Assay for Antileishmanial Screening Against Intracellular Leishmania donovani Amastigotes in THP1 Human Acute Monocytic Leukemia Cell Line

Published on: December 30, 2012

22.5K

Related Concept Videos

Diversity of Protists II01:27

Diversity of Protists II

Alveolates are a group of organisms recognized by the presence of alveoli, which are cytoplasmic sacs located beneath the cell membrane. While their function remains uncertain, alveoli may help regulate water balance by controlling how much water enters and leaves the cell. In dinoflagellates, these structures may serve as armor plates. There are three major types of alveolates: ciliates, which move using cilia; dinoflagellates, which use flagella for movement; and apicomplexans, which are...
112
Overview of Protists01:27

Overview of Protists

Protists are diverse eukaryotic microorganisms that lack the specialized tissues of plants and animals and the chitinous cell walls of fungi. Their early divergence within Eukarya resulted in structural, functional, and ecological diversity. They are classified into supergroups such as Archaeplastida, Excavata, Amoebozoa, Rhizaria, Alveolata, and Stramenopiles, determined through genetic analysis and structural similarities.Structural and Functional AdaptationsProtists have various adaptations...
125
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Diversity of Protists I01:15

Diversity of Protists I

Excavata is a diverse group of protists that includes both chemoorganotrophic and phototrophic species, with some thriving in anaerobic environments. Among the key groups within Excavata are diplomonads and parabasalids, which are flagellated protists that lack mitochondria and chloroplasts. These microorganisms typically inhabit anoxic environments, such as the intestines of animals, where they exist either symbiotically or as parasites, relying on fermentation for energy production. Some...
101
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K